©2022 Stanford Medicine
Autologous Bone Marrow Transplantation in Acute Non-Lymphoblastic Leukemia During First or Subsequent Remission
Not Recruiting
Trial ID: NCT00186381
Purpose
Evaluate the role of high dose chemotherapy with autologous hematopoietic cell
transplantation for AML.
Official Title
Autologous Bone Marrow Transplantation for Acute Non-Lymphoblastic Leukemia During First or Subsequent Remission
Stanford Investigator(s)
Laura Johnston
Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)
Robert Negrin
Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)
Sally Arai
Associate Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)
Eligibility
Inclusion Criteria:- must be in remission
- adequate organ function Exclusion Criteria:- prior MDS
- active infection
- liver disease
Intervention(s):
procedure: high dose chemotherapy then autologous hematopoietic cell transplant
Not Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
BMT Referrals
6507230822